Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Freemium model, plan pricing not identified yet
Creators
Daniil Nenashev
No social account linked
Launched
7mo ago
2026-05-01 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Clean up your camera roll one satisfying swipe at a time

    May 1 · 7mo agoLaunch page

Store data

App Store
App Store App Store
Update date not synced
Rating
Rating not syncedRating count not synced
New ratings last mo
—
Price & IAP
FreeIAP data not synced
Current version
—Store metadata

Store assets, rating histograms, install tiers, and screenshots are synced from Apple App Store, Google Play, and Chrome Web Store.

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct39%
  • Organic Search22%
  • Referrals11%
  • Display Ads10%
  • Other18%

Countries

  • Brazil100%

Search

Domain authority —Domain registered 2025-08-16

KeywordMonthly volume
vibe labs370

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-03 · Source page

Pages & changes

Tracked since 2026-05-01

Key pages

Weekly snapshots
thevibelabs.com/ Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Flick get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Flick and what platforms does it support?
Flick is catalogued under Photo Editing & Enhancement: We make apps that just click.. Supported platforms: Mobile App.

Related products in this category

Design / Photo Editing & Enhancement

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.